Literature DB >> 26274834

Central visual pathways in glaucoma: evidence for distal mechanisms of neuronal self-repair.

Samuel D Crish1, David J Calkins.   

Abstract

As in other age-related neurodegenerative diseases, progression of neurodegeneration in glaucoma involves early axonopathy. In glaucoma, this is marked by degradation of active transport along retinal ganglion cell (RGC) axons projecting from the retina to the brain. In experimental systems, transport degradation occurs first in the most distal site in the RGC projection, the superior colliculus (SC) of the midbrain. Even as degradation progresses from one retinotopic sector to the next, important structures in the affected sectors persist, including synapses from RGC axon terminals onto SC neurons. This structural persistence is accompanied by focally increased brain-derived neurotrophic factor in hypertrophic SC astrocyte glia and defines a therapeutic window of opportunity. Thus, central brain structures in glaucoma may respond to disease-relevant stress by induction of mechanisms useful for maintaining retinal signals.

Entities:  

Mesh:

Year:  2015        PMID: 26274834     DOI: 10.1097/WNO.0000000000000291

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  15 in total

Review 1.  The challenge of regenerative therapies for the optic nerve in glaucoma.

Authors:  David J Calkins; Milos Pekny; Melissa L Cooper; Larry Benowitz
Journal:  Exp Eye Res       Date:  2017-01-30       Impact factor: 3.467

2.  Protective effects of ciliary neurotrophic factor on the retinal ganglion cells by injure of hydrogen peroxide.

Authors:  Wen-Jun Wang; Wei Jin; An-Huai Yang; Zhen Chen; Yi-Qiao Xing
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

Review 3.  The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications.

Authors:  Hongli Yang; Juan Reynaud; Howard Lockwood; Galen Williams; Christy Hardin; Luke Reyes; Cheri Stowell; Stuart K Gardiner; Claude F Burgoyne
Journal:  Prog Retin Eye Res       Date:  2017-03-12       Impact factor: 21.198

4.  Early changes of brain connectivity in primary open angle glaucoma.

Authors:  Paolo Frezzotti; Antonio Giorgio; Francesca Toto; Alessandro De Leucio; Nicola De Stefano
Journal:  Hum Brain Mapp       Date:  2016-08-09       Impact factor: 5.038

Review 5.  Adaptive responses to neurodegenerative stress in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2021-02-25       Impact factor: 19.704

Review 6.  The Role of the IL-20 Subfamily in Glaucoma.

Authors:  Mary K Wirtz; Kate E Keller
Journal:  Mediators Inflamm       Date:  2016-01-20       Impact factor: 4.711

7.  Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma.

Authors:  Wendi S Lambert; Brian J Carlson; Cathryn R Formichella; Rebecca M Sappington; Clarence Ahlem; David J Calkins
Journal:  Front Neurosci       Date:  2017-02-07       Impact factor: 4.677

8.  Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma.

Authors:  Xiao-Ling Yang; Yolandi van der Merwe; Jeffrey Sims; Carlos Parra; Leon C Ho; Joel S Schuman; Gadi Wollstein; Kira L Lathrop; Kevin C Chan
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

9.  Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma.

Authors:  Pete A Williams; James R Tribble; Keating W Pepper; Stephen D Cross; B Paul Morgan; James E Morgan; Simon W M John; Gareth R Howell
Journal:  Mol Neurodegener       Date:  2016-04-06       Impact factor: 14.195

10.  Targeted Delivery of Mitochondrial Calcium Channel Regulators: The Future of Glaucoma Treatment?

Authors:  Leanne T Y Cheung; Abby L Manthey; Jimmy S M Lai; Kin Chiu
Journal:  Front Neurosci       Date:  2017-11-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.